These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33362215)

  • 1. Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and "normal" liver tissues.
    Bortolami M; Comparato A; Benna C; Errico A; Maretto I; Pucciarelli S; Cillo U; Farinati F
    PLoS One; 2020; 15(12):e0244356. PubMed ID: 33362215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusterin contributes to hepatitis C virus-related hepatocellular carcinoma by regulating autophagy.
    Fu N; Du H; Li D; Lu Y; Li W; Wang Y; Kong L; Du J; Zhao S; Ren W; Han F; Wang R; Zhang Y; Nan Y
    Life Sci; 2020 Sep; 256():117911. PubMed ID: 32504756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy-related genes Raptor, Rictor, and Beclin1 expression and relationship with multidrug resistance in colorectal carcinoma.
    Shuhua W; Chenbo S; Yangyang L; Xiangqian G; Shuang H; Tangyue L; Dong T
    Hum Pathol; 2015 Nov; 46(11):1752-9. PubMed ID: 26363527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy.
    Chang Z; Shi G; Jin J; Guo H; Guo X; Luo F; Song Y; Jia X
    Int J Mol Med; 2013 Jun; 31(6):1449-56. PubMed ID: 23588698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and clinical significances of Beclin1, LC3 and mTOR in colorectal cancer.
    Wu S; Sun C; Tian D; Li Y; Gao X; He S; Li T
    Int J Clin Exp Pathol; 2015; 8(4):3882-91. PubMed ID: 26097572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous activation of impaired autophagy and the mammalian target of rapamycin pathway in oral squamous cell carcinoma.
    Yin X; Hu L; Feng X; Wang H; Zhang C; Wang H; Wang S
    J Oral Pathol Med; 2019 Sep; 48(8):705-711. PubMed ID: 31132188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy-related gene LC3 expression in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resection.
    Lin CW; Chen YS; Lin CC; Lee PH; Lo GH; Hsu CC; Hsieh PM; Koh KW; Chou TC; Dai CY; Huang JF; Chuang WL; Chen YL; Yu ML
    Clin Transl Gastroenterol; 2018 Jul; 9(6):166. PubMed ID: 29961754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.
    Navarro-Villarán E; de la Cruz-Ojeda P; Contreras L; González R; Negrete M; Rodríguez-Hernández MA; Marín-Gómez LM; Álamo-Martínez JM; Calvo A; Gómez-Bravo MA; de la Cruz J; Padillo J; Muntané J
    Cell Physiol Biochem; 2020 May; 54(3):457-473. PubMed ID: 32369692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIF1A-AS1 promoted starvation-induced hepatocellular carcinoma cell apoptosis by reducing HIF-1α/mTOR-mediated autophagy.
    Hong F; Gao Y; Li Y; Zheng L; Xu F; Li X
    World J Surg Oncol; 2020 May; 18(1):113. PubMed ID: 32473641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection.
    Hsu CC; Hsieh PM; Chen YS; Lo GH; Lin HY; Dai CY; Huang JF; Chuang WL; Chen YL; Yu ML; Lin CW
    Cancer Med; 2019 Jul; 8(7):3453-3463. PubMed ID: 31094090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.
    Li D; Liu X; Lin L; Hou J; Li N; Wang C; Wang P; Zhang Q; Zhang P; Zhou W; Wang Z; Ding G; Zhuang SM; Zheng L; Tao W; Cao X
    J Biol Chem; 2011 Oct; 286(42):36677-85. PubMed ID: 21878637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoting colonization in metastatic HCC cells by modulation of autophagy.
    Peng YF; Shi YH; Shen YH; Ding ZB; Ke AW; Zhou J; Qiu SJ; Fan J
    PLoS One; 2013; 8(9):e74407. PubMed ID: 24058558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G
    Lei Y; Xu X; Liu H; Chen L; Zhou H; Jiang J; Yang Y; Wu B
    Autophagy; 2021 Dec; 17(12):4423-4441. PubMed ID: 33866937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma.
    Lu C; Ning Z; Wang A; Chen D; Liu X; Xia T; Tekcham DS; Wang W; Li T; Liu X; Liu J; Qi H; Luo H; Du J; Ma C; Yan Q; Liu J; Xu G; Piao HL; Tan G
    Cancer Lett; 2018 Nov; 436():139-148. PubMed ID: 30056112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors.
    Golob-Schwarzl N; Krassnig S; Toeglhofer AM; Park YN; Gogg-Kamerer M; Vierlinger K; Schröder F; Rhee H; Schicho R; Fickert P; Haybaeck J
    Eur J Cancer; 2017 Sep; 83():56-70. PubMed ID: 28715695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylated mTOR expression as a predictor of survival after liver resection for colorectal liver metastases.
    Konishi T; Yoshidome H; Shida T; Furukawa K; Takayashiki T; Kuboki S; Takano S; Miyazaki M; Ohtsuka M
    J Surg Oncol; 2021 Sep; 124(4):598-606. PubMed ID: 34061356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
    Zhang M; Liu S; Chua MS; Li H; Luo D; Wang S; Zhang S; Han B; Sun C
    Cell Death Dis; 2019 Aug; 10(8):612. PubMed ID: 31406106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NPRL2 down-regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppression.
    Wang YC; Tsai MC; Chen YS; Hsieh PM; Hung CM; Lin HY; Hsu YC; Yeh JH; Hsiao P; Su YC; Ma CH; Lee CY; Lin CC; Shu CW; Li YC; Tsai MH; Lin JY; Peng WH; Yu ML; Lin CW
    Hepatol Commun; 2022 Dec; 6(12):3563-3577. PubMed ID: 36321403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.